- Home
- MOBX vs DTIL Comparison
MOBX vs DTIL Comparison
Compare MOBX & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOBX
- DTIL
- Stock Information
- Founded
- MOBX 2020
- DTIL 2006
- Country
- MOBX United States
- DTIL United States
- Employees
- MOBX N/A
- DTIL N/A
- Industry
- MOBX
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- MOBX
- DTIL Health Care
- Exchange
- MOBX Nasdaq
- DTIL Nasdaq
- Market Cap
- MOBX 57.1M
- DTIL 55.3M
- IPO Year
- MOBX N/A
- DTIL 2019
- Fundamental
- Price
- MOBX $0.93
- DTIL $4.61
- Analyst Decision
- MOBX
- DTIL Strong Buy
- Analyst Count
- MOBX 0
- DTIL 2
- Target Price
- MOBX N/A
- DTIL $47.00
- AVG Volume (30 Days)
- MOBX 1.7M
- DTIL 78.0K
- Earning Date
- MOBX 08-13-2025
- DTIL 11-03-2025
- Dividend Yield
- MOBX N/A
- DTIL N/A
- EPS Growth
- MOBX N/A
- DTIL N/A
- EPS
- MOBX N/A
- DTIL N/A
- Revenue
- MOBX $10,984,000.00
- DTIL $1,261,000.00
- Revenue This Year
- MOBX N/A
- DTIL N/A
- Revenue Next Year
- MOBX N/A
- DTIL $135.19
- P/E Ratio
- MOBX N/A
- DTIL N/A
- Revenue Growth
- MOBX 180.13
- DTIL N/A
- 52 Week Low
- MOBX $0.55
- DTIL $3.61
- 52 Week High
- MOBX $2.47
- DTIL $10.71
- Technical
- Relative Strength Index (RSI)
- MOBX 45.49
- DTIL 40.75
- Support Level
- MOBX $1.00
- DTIL $4.86
- Resistance Level
- MOBX $1.19
- DTIL $5.17
- Average True Range (ATR)
- MOBX 0.16
- DTIL 0.24
- MACD
- MOBX -0.01
- DTIL -0.03
- Stochastic Oscillator
- MOBX 14.17
- DTIL 16.18
About MOBX Mobix Labs Inc.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.